E I D Parry India (EIDPARRY) Q4 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 23/24 earnings summary
17 Sep, 2026Executive summary
Revenue from operations declined 3% year-over-year to ₹2,809 crore due to policy changes on ethanol, sugar exports, lower recovery from climatic changes, and plant downtime.
EBITDA dropped 42% to ₹307 crore, and profit after tax fell 46% to ₹107 crore, reflecting a challenging year impacted by regulatory and environmental headwinds.
The company continued its strategic shift from commodity sugar to value-added food, bioenergy, and nutrition segments, with non-sugar revenues rising to 33% of turnover.
Financial highlights
Standalone revenue: ₹2,809 crore (FY24) vs ₹2,895 crore (FY23).
EBITDA: ₹307 crore (FY24) vs ₹527 crore (FY23).
PAT: ₹107 crore (FY24) vs ₹197 crore (FY23).
EPS: ₹6.03 (FY24) vs ₹11.09 (FY23).
Dividend: ₹4 per share interim, treated as final for FY24.
Net worth: ₹2,919 crore (up 1.3% YoY).
Debt-equity ratio: 0.36 (vs 0.18 in FY23).
Outlook and guidance
Expectation of improved profitability in FY25, driven by better sugar business performance and new distillery capacity, though ethanol policy restrictions may impact near-term distillery utilization.
Retail sales projected to grow, targeting 200,000 outlets in South India by 2025.
Continued focus on expanding non-sugar revenues and asset-light business models.
Latest events from E I D Parry India
- Revenue up 3%, profit and EBITDA down on higher costs; margin gains in value-added products.EIDPARRY
Q1 26/27 - Revenue up 22% YoY, but profit fell on exceptional items and refinery closure; focus shifts to margin growth.EIDPARRY
Q4 25/26 - Q3 FY26 revenue up 18% YoY; profit after tax at Rs. 232 Cr; segment results mixed.EIDPARRY
Q3 25/26 - H1 FY26 profitability rose on higher realizations and cost control, despite volume pressures.EIDPARRY
Q2 25/26 - Revenue and profit declined year-over-year, but Consumer Products and Distillery segments grew strongly.EIDPARRY
Q1 24/25 - Revenue up, profits down; distillery and retail strong, borrowings rise, nutraceuticals weak.EIDPARRY
Q2 24/25 - Q3 FY25 revenue up 12% YoY to ₹8,720 crore; distillery and CPG growth offset sugar pressures.EIDPARRY
Q3 24/25 - Consolidated revenue rose to Rs. 31,609 crore, but impairments led to a standalone PAT loss.EIDPARRY
Q4 24/25 - Improved realizations and distillery gains offset lower volumes; revenue and profit increased.EIDPARRY
Q1 25/26